Literature DB >> 16280553

Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B.

Guillaume Bompard1, Stewart J Sharp, Gilles Freiss, Laura M Machesky.   

Abstract

Numerous scaffold proteins coordinate signals from the environment with actin-based protrusions during shape change and migration. Many scaffolds integrate signals from Rho-family GTPases to effect the assembly of specific actin structures. Here we investigate the mechanism of action MIM-B (missing in metastasis-B) on the actin cytoskeleton. MIM-B binds actin monomer through a WASP homology 2 motif, bundles actin filaments via an IRSp53/MIM domain, and is a long isoform of MIM, a proposed metastasis suppressor. We analysed the activity of MIM-B toward the actin cytoskeleton as well as its potential link to cancer metastasis. Endogenous MIM-B protein is widely expressed and its expression is maintained in various metastatic cell lines. MIM-B induces lamellipodia-like actin-rich protrusions. The IRSp53/MIM domain of MIM-B, as well as Rac activity are required to induce protrusions, but not the WASP homology 2 motif. MIM-B binds and activates Rac via its IRSp53/MIM domain, but this is not sufficient to induce lamellipodia. Finally, our data revealed that actin bundling and Rac-binding properties of MIM-B are not separable. Thus, MIM-B is unlikely to be a metastasis suppressor but acts as a scaffold protein that interacts with Rac, actin and actin-associated proteins to modulate lamellipodia formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280553     DOI: 10.1242/jcs.02640

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  53 in total

Review 1.  BAR domain competition during directional cellular migration.

Authors:  Gabriel A Quiñones; Anthony E Oro
Journal:  Cell Cycle       Date:  2010-07-01       Impact factor: 4.534

2.  Dimerization is necessary for MIM-mediated membrane deformation and endocytosis.

Authors:  Meng Cao; Tailan Zhan; Min Ji; Xi Zhan
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

3.  Structural basis for the actin-binding function of missing-in-metastasis.

Authors:  Sung Haeng Lee; Frederic Kerff; David Chereau; François Ferron; Alexandra Klug; Roberto Dominguez
Journal:  Structure       Date:  2007-02       Impact factor: 5.006

4.  Abba promotes PDGF-mediated membrane ruffling through activation of the small GTPase Rac1.

Authors:  Datong Zheng; Shuqiong Niu; Dan Yu; Xiaoguo H Zhan; Xianchun Zeng; Bota Cui; Yanping Chen; Jennifer Yoon; Stuart S Martin; Xiang Lu; Xi Zhan
Journal:  Biochem Biophys Res Commun       Date:  2010-09-26       Impact factor: 3.575

5.  Regulation of IRSp53-dependent filopodial dynamics by antagonism between 14-3-3 binding and SH3-mediated localization.

Authors:  Jeffrey M Robens; Lee Yeow-Fong; Elsa Ng; Christine Hall; Ed Manser
Journal:  Mol Cell Biol       Date:  2009-11-23       Impact factor: 4.272

6.  miR-96 promotes the growth of prostate carcinoma cells by suppressing MTSS1.

Authors:  Libo Xu; Jiateng Zhong; Baofeng Guo; Qi Zhu; Hang Liang; Naiyan Wen; Wenjing Yun; Ling Zhang
Journal:  Tumour Biol       Date:  2016-05-11

Review 7.  BAR domain proteins regulate Rho GTPase signaling.

Authors:  Pontus Aspenström
Journal:  Small GTPases       Date:  2014

8.  The SH3 domain distinguishes the role of I-BAR proteins IRTKS and MIM in chemotactic response to serum.

Authors:  Lushen Li; Hongyu Liu; Shaneen S Baxter; Ning Gu; Min Ji; Xi Zhan
Journal:  Biochem Biophys Res Commun       Date:  2016-09-28       Impact factor: 3.575

9.  I-BAR protein antagonism of endocytosis mediates directional sensing during guided cell migration.

Authors:  Gabriel A Quinones; Janet Jin; Anthony E Oro
Journal:  J Cell Biol       Date:  2010-04-12       Impact factor: 10.539

10.  Downregulation of metastasis suppressor 1(MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer.

Authors:  Ke Liu; Gefang Wang; Houzhong Ding; Ying Chen; Guanzhen Yu; Jiejun Wang
Journal:  BMC Cancer       Date:  2010-08-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.